Join
Live feed
·
INSIDERFilingvia Quantisnow
Corcept Therapeutics Incorporated logo

Chief Development Officer Guyer William sold $364,070 worth of shares (4,500 units at $80.90), decreasing direct ownership by 85% to 787 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CORT· Corcept Therapeutics Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CORT (Corcept Therapeutics Incorporated) and more on Quantisnow.